Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

Vaccines against respiratory syncytial virus: The time has finally come

(2016) Barney S. Graham   VACCINE

Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics

(2015) Natalie I Mazur et al.   Lancet Respiratory Medicine

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats

(2013) Tobias Kamphuis et al.   Influenza and Other Respiratory Viruses

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice

(2012) Tobias Kamphuis et al.   PLoS One

Systematic study of bimodal suspensions of latex nanoparticles using dynamic light scattering

(2011) Å.K. Jamting et al.   ADVANCED POWDER TECHNOLOGY

Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein

(2010) M. Magro et al.   JOURNAL OF VIROLOGY

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates

(2010) Vasco Filipe et al.   PHARMACEUTICAL RESEARCH

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation

(2010) Toon Stegmann et al.   VACCINE

A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions

(2008) Christopher M. Hoo et al.   JOURNAL OF NANOPARTICLE RESEARCH

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE